Business Insights, March 2010, Pages: 123
and drinks manufacturers R&D spend ($m), 2005-2009 - Danone
- DSM
- General Mills
- Kraft
- P&G Future R&D Strategies in Food & Drinks: Evolution from Orthodox Approaches to Open InnovationModels
Business Insights, Feb 2007, Pages: 112
will enable you to...
-Enhance the effectiveness of your innovationstrategies with this report’s analysis of the innovationmodels of leading food and drink manufacturers, including Procter & Gamble
Saugatuck Technology, Dec 2011, Pages: 14
.
Saugatuck's newest report, “Mapping, Planning, and Benefiting from Global IT Innovation,” not only explains how shifts in innovation investment can affect provider profits and user adoption strategies
GBI Research, May 2011, Pages: 69
Facing Generics Industry 23
4.3.1 LCM Strategy Adopted by Innovators to Stay Competitive Poses Challenge to Generics 23
4.3.2 R&D Productivity at a Low for Innovator Companies – Likely to Affect Generics
John Wiley and Sons Ltd, July 2010, Pages: 416
Transfer Cases.
11.12 Technology Transfer Strategy.
11.13 Summary.
11.14 Questions for Class Discussion.
12 Models for Implementing Incremental and Radical Innovation.
12.1 Defining Innovation.
12
Datamonitor, March 2011, Pages: 81
and cut costs through elimination of duplicate operations, while externalization of R&D enables low-risk access to innovative pipeline products. Ultimately, such strategies can be used to increase
Decision Resources, Inc., Sep 2009, Pages: 24
Can radical changes to the structures and strategies of pharmaceutical R&D operations—such as creating more entrepreneurial environments modeled upon biotech companies—increase their productivity
Business Insights, Oct 2006, Pages: 136
these are evolving. In addition, it outlines key best practices to improve productivity and reduce R&D costs.
Use this report to identify key areas of growth, effective strategies and innovative technologies
Frost & Sullivan, Sep 2010, Pages: 66
participants, and strategies for effective R&D management. It includes analysis of emerging business models in the 60 GHz space. In this research, Frost & Sullivan’s expert analysts thoroughly examine
CBR Pharma Insights, Jan 2011, Pages: 55
Pharma to change its business model. The evolving model is one grounded in collaboration. Companies are no longer relying solely on their own internal R&D programs for innovation; they are looking outside
SupplierBusiness, Nov 2010, Pages: 95
“Supplying PSA” analyses the carmaker’s procurement strategy including its vertical integration, supplier selection criteria and biases, together with a host of aspects defining the current
Decision Resources, Inc., Nov 2011
-cycle management, innovativeR&D, established products, hybrid business model, branded generics, emerging markets, Japanese generics market, generics strategies of 8 Big Pharma companies, generics
Decision Resources, Inc., Nov 2011
to better access academic research and researchers? What is open-access R&D? What is the academic superstar model?
- Many Big Pharma companies embrace the strategy of externalizing R&D to improve R
GBI Research, June 2011, Pages: 77
the key capabilities and models of major technology solution providers with your requirements and optimize your R&D costs
- Develop market entry and market expansion strategies by identifying the key
Decision Resources, Inc., July 2009, Pages: 29
Under tremendous pressure to refuel dwindling development pipelines and improve R&D productivity, pharmaceutical companies are seeking external sources of products and innovation. Biotech companies
JZMed Inc., Oct 2011, Pages: 215
industry is currently developing, what outsourcing strategies are evolving, what new service models and new technologies have been developed, etc.
Based on the in-depth analysis of a series of growth
Business Insights, June 2002, Pages: 254
the structures and strategies to support it. By drawing on research spanning seven major sectors, from automotive to life sciences, you can ensure your business profits from innovation by ordering a copy
